+265.7%
MRNA vs PR
+88.0%
+177.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.3% | +1.9% | +3.4% | +4.7% |
| 7D | +14.6% | -16.4% | +31.1% | +20.1% |
| 30D | +29.4% | -1.9% | +31.3% | +29.1% |
| 3M | +371.9% | +8.0% | +364.0% | +359.7% |
| 6M | +421.0% | +4.1% | +416.9% | +409.4% |
| YTD | +762.0% | +58.7% | +703.3% | +633.4% |
| 1Y | +944.8% | +75.8% | +868.9% | +760.7% |
| All | +265.7% | +88.0% | +177.7% | +171.0% |
Cumulative growth
Daily Returns
Daily percentage return beside PR.
Daily Out/Under-Performance
Portfolio return minus PR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling